Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Files An 8-K Regulation FD DisclosureItem 7.01
Regulation FD Disclosure.
On November 26, 2018, Rocket Pharmaceuticals, Inc. made available an updated corporate presentation on its website. A copy of the corporate presentation is furnished herewith as Exhibit 99.1 and incorporated by reference herein.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
|
Item 9.01 |
Financial Statements and Exhibits |
|
Exhibit No. |
Description |
|
Rocket Pharmaceuticals, Inc. Presentation, dated November 26, 2018 |
ROCKET PHARMACEUTICALS, INC. Exhibit…To view the full exhibit click here